IMAX vs Xperi
IMAX and XPER side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IMAX and XPER compare
IMAX is the larger company, worth 8.9 times as much as Xperi ($2.6B against $289M).
IMAX grew revenue faster over the last twelve months (14.8% versus −3.9% for Xperi).
IMAX scores higher on the StockData Score (9 against 4 for Xperi), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IMAX | XPER |
|---|---|---|
| Size and price | ||
| Market cap | $2.6B | $289M |
| Share price | $46.76 | $5.93 |
| Change, 1 year | 33.2% | −5.9% |
| Change, 5 years | 172% | −67.4% |
| Beta (5Y) | 0.47 | 1.02 |
| Employees | 679 | 250 |
| StockData Score | ||
| Total score | 9 (better) | 4 |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 64.9× | – |
| P/S | 6.2× | 0.6× (better) |
| P/B | 7.2× | – |
| EV/EBITDA | 17.1× | – |
| P/FCF | 20.3× (better) | 102× |
| FCF yield | 4.9% (better) | 0.98% |
| Fair value | $33.02 | – |
| Margin of safety | −41.6% | – |
| Growth | ||
| Revenue growth (TTM) | 14.8% (better) | −3.9% |
| Revenue growth, 5Y average | 24.5% (better) | 3.6% |
| Net income growth (TTM) | 24.8% | – |
| EPS growth (TTM) | 20.0% | – |
| Profitability | ||
| Gross margin | 59.6% | – |
| Operating margin | 20.2% (better) | −2.4% |
| Net margin | 9.8% | – |
| FCF margin | 30.4% (better) | 0.62% |
| Return on equity | 12.1% | – |
| Return on invested capital | 31.1% | – |
| Financial health | ||
| Interest coverage | 11.2× (better) | −3.9× |
| Current ratio | – | 2.48 |
| Altman Z-score | 3.69 (better) | −0.18 |
| Piotroski F-score | 7 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 93.7% | 93.2% |
| Held by insiders | 21.6% | 5.9% |
| Insider net buying, 12 months | −$70.2M | – |
| Short interest, % of float | 15.6% | 12.3% |
Go deeper
- IMAX stock overview
- IMAX income statement
- IMAX valuation and score
- XPER stock overview
- XPER income statement
- XPER valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.